self questionnaires
OtherFSFI, QLQ-C30, BR23, ELD15, HADS, GDS 15, FACIT, BIS
NCT Number: NCT03946579
The purpose of this study is to assess the quality of life and sexuality during adjuvant chemotherapy in over 65 years old patients with breast cancer
Looking for future studies?
Notify Me65 year and older
Female
Interventional
Not applicable
CHU Amiens, Amiens, France
Evaluation of quality of life and sexual health will be assessed by the mean of validated self questionnaires after surgery for breast cancer, before and after adjuvant chemotherapy and one year after initial surgery
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
FSFI, QLQ-C30, BR23, ELD15, HADS, GDS 15, FACIT, BIS
Time frame: one year
assessment with Female sexual functionnal index (FSFI) self questionnaire
Time frame: one year
assessment with the Quality of life questionnaire (QLQ-C30) that contains 30 items dealing with fatigue, pain, nausea and vomiting, general condition and social, emotional and cognitive functions.
Time frame: one year
assessment with body image scale that contains 10 items dealing with body image
Time frame: one year
assessment with Functionnal assessment of chronic illness therapy-Fatigue (FACIT-F) self questionnaire that contains 13 items dealing with fatigue
Time frame: one year
assessment with Hospital anxiety and depression scale (HADS) that contains 15 items dealing with anxiety
Time frame: one year
assessment geriatric depression scale (GDS 15 self questionnaire) that contains 15 item dealing with depression
Centre Henri Becquerel
Other
Evaluation of the Quality of Life and Sexuality of Patients Over 65 Years of Age Undergoing Adjuvant Treatment for Breast Cancer
Acronym: QUALITY-AGE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details